Page 19 - ஜுவான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Rep Bass: We have to find a way to hold police officers accountable (Graphic Warning)
foxnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foxnews.com Daily Mail and Mail on Sunday newspapers.
New this week: Big Shot, Mare of Easttown and Monday
The Associated Press
FacebookTwitterEmail
This combination photo shows promotional art for Big Shot, premiering April 16 on Disney Plus, left, Mare of Easttown, a limited series premiering April 18 on HBO Max and Monday, and IFC Film premiering April 16. (Disney+/HBO/IFC Films via AP)AP
Here’s a collection curated by The Associated Press’ entertainment journalists of what’s arriving on TV, streaming services and music platforms this week.
MOVIES Sebastian Stan’s devoted followers are certainly getting a fair amount of him this spring on Disney+ in “The Falcon and the Winter Soldier.” But for anyone looking for something outside Bucky Barnes and the Marvel universe, he’s also starring in the steamy new romance “Monday,” both in theaters and on video on demand starting Friday. Stan stars opposite Denise Gough as a pair of strangers who start an intense summer affair in Greece in director Argyris P
Aburto defiende la actuación de la Ertzaintza en Bilbao mientras crecen las críticas internas
diariovasco.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariovasco.com Daily Mail and Mail on Sunday newspapers.
14.03.2021
Valneva: Valneva, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer today announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new dose regimens and is anticipated to be the final Phase 2 study readout before a decision to progress into pivotal Phase 3 studies. As announced in December 2020, VLA15-221 is a randomized, observer-blind, placebo-controlled Phase 2 study. It will be the first VLA15 study to include a pediatric population (aged 5-17 years). Overall, the study will enroll approximately 600 healthy participants (aged 5-65 years) who will receive VLA15 or placebo. It will compare the three-dose vaccination schedule (Month 0-2-6) with a two-dose schedule (Month 0-6). Juan Carlos Jaramillo, Chief Medical Officer of Valneva commented, “This trial initiation marks an important step in the development of VLA15 toward a potential licensure. Including a pe
vimarsana © 2020. All Rights Reserved.